Core Scientific, Inc. Common Stock (CORZ)
Official siteTECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ
Market Cap: $4.68B
Last updated: Nov 17, 2026 at 11:05 AM ET
Core Scientific, Inc. Common Stock (CORZ) P/E Ratio & Valuation Multiples
Core Scientific, Inc. Common Stock (CORZ) trades at 38.1x trailing earnings and 10.8x sales. Its forward P/E is 19.5x. The median P/E across 7 similar companies is 14.6x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 95.4% higher over the next year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 38.1x |
| Forward P/E | 19.5x |
| Price to sales | 10.8x |
| PEG | N/A |
|---|---|
| FCF yield | -20.7% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CORZ
What is CORZ's forward P/E ratio?
Core Scientific, Inc. Common Stock has a forward P/E ratio of 19.5x.
Is CORZ stock overvalued?
GNG's valuation label for CORZ is Overvalued. Its P/E of 38.1x compares with a median of 14.6x across 7 similar companies.
What is CORZ's price to sales ratio?
Core Scientific, Inc. Common Stock has a price to sales ratio of 10.8x.
CORZ pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors